𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin

✍ Scribed by Xiaodong Zhu; Jiin Leaw; Weilie Gu; Yiying Qian; Hongyu Du; Biyun Wang; Xiaonan Hong; Jiliang Yin


Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
291 KB
Volume
134
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II trial of weekly high dose con
✍ Enrique Aranda; AndrΓ©s Cervantes; Javier Dorta; Esperanza Blanco; Carlos FernΓ‘nd πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

Phase II trial of 5-fluorouracil, interf
✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d